about
Treatment for bacteraemia due to Staphylococcus aureusAcute rheumatic fever: an unusual cause of fever in a returned travelerMycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenzaSuccessful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report.Iatrogenic meningitis caused by Neisseria sicca/subflava after intrathecal contrast injection, Australia.Peritonitis due to Curvularia inaequalis in an elderly patient undergoing peritoneal dialysis and a review of six cases of peritonitis associated with other Curvularia sppSuccessful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort studyMycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settingsIncidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections.Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic areaCandida infective endocarditis: an observational cohort study with a focus on therapyRisk factors for Mycobacterium ulcerans infection, southeastern AustraliaCandida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia.A case of Kingella kingae endocarditis complicated by native mitral valve ruptureCandida infective endocarditis.The tip of the iceberg: opportunistic screening for Chlamydia trachomatis in asymptomatic patients attending a young people's health clinic reveals a high prevalence--a pilot study.Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014.Effectiveness of a care bundle to reduce central line-associated bloodstream infections.Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective.Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.Q fever outbreak at a cosmetics supply factory.Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.The characteristics and outcome of infective endocarditis involving implantable cardiac devices.Transmission of tuberculosis infection in a commercial office.Forgotten but not gone - Scrofuloderma in a migrant student from India.Melioidosis in tsunami survivors.Case cluster of necrotizing fasciitis and cellulitis associated with vein sclerotherapy.AIDS and heart disease: is cardiac surgery justified?Updated Creutzfeldt-Jakob disease infection control guidelines: sifting facts from fiction.Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa.Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
P50
Q24241085-E2AFAD07-C358-47B9-A699-553B218884B7Q28193899-920B89F4-3CA5-4366-B628-436DCE7BE13EQ28543227-CDA7256A-1D7F-43B5-AE99-08BFA8583495Q30358381-6786C446-88F2-4B65-A3F0-28712FDEC2E9Q30367636-32872EAA-8121-4517-AF3B-47B1E51C917CQ33331051-6091A4A8-070C-481C-AA50-D50FB1DECC8FQ33678630-76F8B2DD-A782-4E51-BD84-A1028C209FAEQ34041674-DC6F1EB2-1FB1-490C-B1B0-870E14B90497Q34137837-7C088895-2385-4D6F-8840-73FE170CEDF8Q34855365-E0E89A7F-AD45-4553-9F31-5874499C2D62Q34918287-B06EFA23-B23B-494F-A894-028AF8B0427EQ34978950-F67CC327-7D30-4C0D-A219-FB76290694E0Q35030247-455319F7-2005-46E4-8BBC-97F2A1E9126CQ35083532-27500585-BE36-415E-8FD3-DAB134F4C33EQ35168901-E1F3330F-A35B-4E67-A583-FADB6396D964Q36033978-B4F03292-5402-41CF-BC67-6F1F2C25DA71Q36311524-01AC183C-006A-4DD5-8952-6F59AD4DFCFBQ36708328-65E06D1C-6216-4EAC-8C28-2B79E6C6190DQ36832381-7E45A29E-E53E-48D4-9443-FF8E7A2CE050Q37377048-FDFCCD1D-A02D-4AB7-85E4-4727591DEC62Q37863410-A31B335B-716C-4BAA-9ACE-9408D51AC11DQ38284470-7C79FCEF-0B91-49DC-80FE-D29AA720D8A8Q38372980-C5E0B22F-A0AF-48B7-94EE-22D84FF9AB51Q38609374-500CAA4E-3713-4003-9A9A-8B96EFAB7692Q38882906-4E22553F-2378-4504-8ECA-2A9C4781FD04Q40484882-DEF019EC-D010-42C5-A85E-02D9367C5715Q41365533-D8D55E95-A5D8-46A8-99B8-198A6FD0345FQ41442637-4CC63E66-8C0D-4F37-B7D5-950A290C18D0Q41614143-2216BDFE-4ACA-41B9-8012-F7FDFC290E35Q41687262-49BA2B9D-E2BF-4BE6-BE42-74A6EBF69991Q42228419-61D63312-1A2A-48DE-BBCA-2AB34B46BE19Q42251303-B715D5CB-3199-412A-9C30-3365EDA0E86FQ43188885-8F03E615-AEB3-4D36-845B-A9AF0E246A69Q43230459-6E553548-5661-462D-B212-E52CDA16E46BQ43438204-F42C6FF0-8526-4F7E-8B28-70BE0BFF73C7Q43636220-8A2DD231-6D2F-49CA-8BB6-A829CD566BC7Q43725243-CE7B68B4-DE14-425E-8F65-1636D7AA2853Q43729519-0FC477A6-C424-4EC1-B3C0-67F9EDB2A2FBQ43917796-5C8A698D-3FCE-444F-A18E-69504DF479C1Q43996918-6171D1F0-523B-411F-9F13-A3A76AB825EE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eugene Athan
@ast
Eugene Athan
@en
Eugene Athan
@es
Eugene Athan
@nl
Eugene Athan
@sl
type
label
Eugene Athan
@ast
Eugene Athan
@en
Eugene Athan
@es
Eugene Athan
@nl
Eugene Athan
@sl
prefLabel
Eugene Athan
@ast
Eugene Athan
@en
Eugene Athan
@es
Eugene Athan
@nl
Eugene Athan
@sl
P106
P108
P1153
6701602230
P21
P31
P496
0000-0001-9838-6471